Life Sciences Regulatory & Quality Consulting

Regulatory & Quality Judgment for Life Sciences.

Senior regulatory, CMC, and quality support that connects evidence to decisions, execution, and inspection readiness.

Explore Services or Read XGene Insights

Life-sciences evidence-to-execution system

Regulatory evidence, CMC control strategy, quality systems, and inspection readiness converge through senior technical judgment into execution.

Senior judgment Decision Core evidence → execution
Regulatory evidenceAgency context
CMC control strategyProduct · Process
Quality systemsData · CAPA
Inspection readinessExecute · Sustain
ExecutionDefensible action

Where teams need help

Where does the pressure sit today?

Nine established service lines span the full product lifecycle. These four pathways organize that depth around common points of regulatory and operational pressure.

Regulatory strategy connected to execution.

Submission planning, technical evidence, quality controls, and inspection readiness are treated as one decision system.

Discuss the regulatory pathway

CMC Strategy, Module 3 & Submission Readiness

Connect development evidence, control strategy, analytical justification, manufacturing history, and Module 3 authorship.

Explore CMC readiness

FDA 483 / Warning Letter & GMP Remediation

Structure response and remediation around evidence, systemic root cause, accountable CAPA, and effectiveness.

Explore remediation

Inspection Readiness & PAI Support

Test whether people, records, retrieval, and front-room execution can demonstrate control under inspection.

Explore inspection readiness

AI-Enabled CMC & Regulatory Modernization

Modernize CMC around the evidence and data model—not around the AI tool—with accountable human governance.

Explore AI-enabled CMC

Choose the information format

Use the source, analysis, or format that fits the question.

Regulatory intelligence, Articles, and technical resources show how XGene connects primary evidence to the decisions life sciences teams face.

Read the featured analysis
Featured Article

ALCOA+ Data Completeness — The Deletion Problem FDA Finds First

Read Article

Relationship model

From source evidence to an inspection-ready operating position

The visual system makes the relationship explicit without turning the page into a dashboard.

Regulatory evidence

Guidance, enforcement, source documents, and review context.

Technical decision

CMC strategy, quality controls, data, and product-lifecycle implications.

Operational readiness

Documented execution, verification, inspection response, and sustainment.

Supported pathways: pharmaceutical, biotechnology, medical device, and advanced modalities.

Choose the next step

Bring the issue, evidence, and decision timeline.

The guided intake helps route a focused consulting conversation without asking for confidential information.